We are Developing a novel molecule class for multiple Disease indications


Relay Life Science offers a novel model for developing therapeutics and positions them for rapid, high value acquisition by a commercial partner.



  • Experienced team of founders and advisory board members

  • Initial studies have shown strong efficacy of our molecule class in treating a range of health issues

  • Broad range of potential indications mitigates risk for investors (various target diseases, multiple exit opportunities, etc.)

  • Multiple development inflection points offer opportunity for exit anywhere between early clinical trials and commercialization


Who we are

Meet our management team and advisory board.

Learn More →


Want to learn more about Recycling Polycarbonyl Redox Therapy?


Contact Us

Have questions? Reach out to our team via our contact page.

Get in Touch →